Economic evaluation of routine infant rotavirus immunisation program in Japan

References

• Rotavirus vaccines. WHO position paper - January 2013. Wkly Epidemiol Rec 2013; 88(5):49-64; PMID:23424730
   PubMedGoogle Scholar
• Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12(2):304-6; PMID:16494759; http://dx.doi.org/10.3201/eid1202.050006
   PubMed Web of Science ®Google Scholar
• Payne DC, Staat MA, Edwards KM, Szilagyi PG, Gentsch JR, Stockman LJ, Curns AT, Griffin M, Weinberg GA, Hall CB, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 2008; 122(6):1235-43; PMID:19047240; http://dx.doi.org/10.1542/peds.2007-3378
   PubMed Web of Science ®Google Scholar
• Newall AT, MacIntyre R, Wang H, Hull B, Macartney K. Burden of severe rotavirus disease in Australia. J Paediatr Child Health 2006; 42(9):521-7; PMID:16925538; http://dx.doi.org/10.1111/j.1440-1754.2006.00915.x
   PubMed Web of Science ®Google Scholar
• Van Damme P, Giaquinto C, Maxwell M, Todd P, Van der Wielen M; REVEAL Study Group. Distribution of rotavirus genotypes in Europe, 2004-2005: the REVEAL Study. J Infect Dis 2007; 195(Suppl 1):S17-25; PMID:17387648; http://dx.doi.org/10.1086/516715
   PubMed Web of Science ®Google Scholar
• Tajiri H, Takeuchi Y, Takano T, Ohura T, Inui A, Yamamoto K, Higashidate Y, Kawashima H, Toyoda S, Ushijima K, et al. The burden of rotavirus gastroenteritis and hospital-acquired rotavirus gastroenteritis among children aged less than 6 years in Japan: a retrospective, multicenter epidemiological survey. BMC Pediatr 2013; 13:83; PMID:23697664; http://dx.doi.org/10.1186/1471-2431-13-83
   PubMed Web of Science ®Google Scholar
• Le Saux N, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW. Canadian immunization monitoring program, Active (IMPACT). Substantial morbidity for hospitalized children with community-acquired rotavirus infections: 2005-2007 IMPACT surveillance in Canadian hospitals. Pediatr Infect Dis J 2010; 29:879-82; PMID:20467353; http://dx.doi.org/10.1097/INF.0b013e3181e20c94
   PubMed Web of Science ®Google Scholar
• Payne DC, Baggs J, Zerr DM, Klein NP, Yih K, Glanz J, Curns AT, Weintraub E, Parashar UD. Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis 2014; 58(2):173-7; PMID:24265355; http://dx.doi.org/10.1093/cid/cit671
   PubMed Web of Science ®Google Scholar
• Hoshino A, Saitoh M, Oka A, Okumura A, Kubota M, Saito Y, Takanashi J, Hirose S, Yamagata T, Yamanouchi H, et al. Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev 2012; 34(5):337-43; PMID:21924570; http://dx.doi.org/10.1016/j.braindev.2011.07.012
   PubMed Web of Science ®Google Scholar
• Kawamura Y, Ohashi M, Ihira M, Hashimoto S, Taniguchi K, Yoshikawa T. Nationwide survey of rotavirus-associated encephalopathy and sudden unexpected death in Japan. Brain Dev 2014; 36(7):601-7; PMID:23972382; http://dx.doi.org/10.1016/j.braindev.2013.07.013
   PubMed Web of Science ®Google Scholar
• Kawamura N, Tokoeda Y, Oshima M, Okahata H, Tsutsumi H, Van Doorn LJ, Muto H, Smolenov I, Suryakiran PV, Han HH. Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life. Vaccine 2011; 29(37):6335-41; PMID:21640780; http://dx.doi.org/10.1016/j.vaccine.2011.05.017
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370(9601):1757-63; PMID:18037080; http://dx.doi.org/10.1016/S0140-6736(07)61744-9
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Ferrante SA, Ciarlet M. Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study. Eur J Pediatr 2010; 169(11):1379-86; PMID:20559656; http://dx.doi.org/10.1007/s00431-010-1242-3
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Thollot F, Garcia-Corbeira P, Damaso S, Han HH, Bouckenooghe A. Immunogenicity and safety of the human rotavirus vaccine RotarixTM co-administered with routine infant vaccines following the vaccination schedules in Europe. Vaccine 2010; 28(32):5272-9; PMID:20538094; http://dx.doi.org/10.1016/j.vaccine.2010.05.057
   PubMed Web of Science ®Google Scholar
• Payne DC, Selvarangan R, Azimi PH, Boom JA, Englund JA, Staat MA, Halasa NB, Weinberg GA, Szilagyi PG, Chappell J, et al. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013. Clin Infect Dis 2015; 61(12):1792-9; PMID:26449565; http://dx.doi.org/10.1093/cid/civ872
   PubMed Web of Science ®Google Scholar
• Chang WC, Yen C, Wu FT, Huang YC, Lin JS, Huang FC, Yu HT, Chi CL, Lin HY, Tate JE, et al. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants. Pediatr Infect Dis J 2001; 33(3):e81-6; http://dx.doi.org/10.1097/INF.0000000000000105
   Web of Science ®Google Scholar
• Lo Vecchio A, Liguoro I, Dias JA, Berkley JA, Boey C, Cohen MB, Cruchet S, Salazar-Lindo E, Podder S, Sandhu B, et al. Rotavirus immunization: Global coverage and local barriers for implementation. Vaccine 2017; 35(12):1637-44; http://dx.doi.org/10.1016/j.vaccine.2017.01.082
   Google Scholar
• Nakagomi T, Nakagomi O, Takahashi Y, Enoki M, Suzuki T, Kilgore PE. Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis 2005; 192(Suppl 1):S106-10; PMID:16088792; http://dx.doi.org/10.1086/431503
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare. Vital statistics of Japan. Tokyo: Ministry of Health, Labour and Welfare; 1997 [in Japanese].
   Google Scholar
• Sato T, Nakagomi T, Nakagomi O. Cost-effectiveness analysis of a universal rotavirus immunisation program in Japan. Jpn J Infect Dis 2011; 64(4):277-83; PMID:21788701
   PubMed Web of Science ®Google Scholar
• Itzler R, O'Brien MA, Yamabe K, Abe M, Dhankhar P. Cost-effectiveness of a pentavalent rotavirus vaccine in Japan. J Med Econ 2013; 16(10):216-27; http://dx.doi.org/10.3111/13696998.2013.831869
   Google Scholar
• Record of proceedings of the committee of Immunisation and Vaccine. Health Science Council, Ministry of Health, Welfare and Labour of Japan. 2013, April ∼2016, Feb (1st meeting∼8th meeting). [Accessed 2016 Jun 15, in Japanese] http://www.mhlw.go.jp/stf/shingi/shingi-kousei.html?tid=127713
   Google Scholar
• Rotavirus working group, Infectious Disease Sectional Committee, Ministry of Health, Welfare and Labour of Japan. Interim report. 2013. [accessed 2016 15 Jun, in Japanese]. Available at: http://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000029637.pdf
   Google Scholar
• Committee to Study Priorities for Vaccine Development Institute of Medicine. Vaccines for the 21st century: a tool for decision making. Washington, DC: National Academy Press; 2000
   Google Scholar
• Walker DG, Hutubessy R, Beutels P. WHO Guide for standardisation of economic evaluations of immunization programmes. Vaccine 2010; 28(11):2356-9; http://dx.doi.org/10.1016/j.vaccine.2009.06.035
   Google Scholar
• Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 2010; 19(4):422-37; PMID:19382128; http://dx.doi.org/10.1002/hec.1481
   PubMed Web of Science ®Google Scholar
• Hoshi SL, Kondo M, Okubo I. Economic evaluation of vaccination programme of 7-valent pneumococcal conjugate vaccine to the birth cohort in Japan. Vaccine 2012; 30(22):3320-8; PMID:22386745; http://dx.doi.org/10.1016/j.vaccine.2012.02.033
   PubMed Web of Science ®Google Scholar
• Rozenbaum MH, Mangen MJ, Giaquinto C, Wilschut JC, Hak E, Postma MJ, Consensus Group on Dutch Rotavirus Vaccination (CoRoVa-Group). Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model. BMC Public Health 2011;11:462; PMID:21663620; http://dx.doi.org/10.1186/1471-2458-11-462
   PubMed Web of Science ®Google Scholar
• Goossens LM, Standaert B, Hartwig N, Hövels AM, Al MJ. The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands. Vaccine 2008; 26(8):1118-27; PMID:18215445; http://dx.doi.org/10.1016/j.vaccine.2007.11.070
   PubMed Web of Science ®Google Scholar
• Jit M, Bilcke J, Mangen MJ, Salo H, Melliez H, Edmunds WJ, Yazdan Y, Beutels P. The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe. Vaccine 2009;27(44):6121-8; PMID:19715781; http://dx.doi.org/10.1016/j.vaccine.2009.08.030
   PubMed Web of Science ®Google Scholar
• Mangen MJ, van Duynhoven YT, Vennema H, van Pelt W, Havelaar AH, de Melker HE. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program? Vaccine 2010; 28(14):2624-35; PMID:20109593; http://dx.doi.org/10.1016/j.vaccine.2010.01.014
   PubMed Web of Science ®Google Scholar
• Zomer TP, van Duynhoven YT, Mangen MJ, van der Maas NA, Vennema H, Boot H, de Melker HE. Assessing the introduction of universal rotavirus vaccination in the Netherlands. Vaccine 2008; 26(29-30):3757-64; PMID:18514975; http://dx.doi.org/10.1016/j.vaccine.2008.04.039
   PubMed Web of Science ®Google Scholar
• Tu HA, Rozenbaum MH, de Boer PT, Noort AC, Postma MJ. An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”. BMC Infect Dis 2013; 13:54; PMID:23363553; http://dx.doi.org/10.1186/1471-2334-13-54
   PubMed Web of Science ®Google Scholar
• Knoll S, Mair C, Benter U, Vouk K, Standaert B. Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany? Health Econ Rev 2013; 3(1):27; PMID:24246029; http://dx.doi.org/10.1186/2191-1991-3-27
   PubMedGoogle Scholar
• Aidelsburger P, Grabein K, Böhm K, Dietl M, Wasem J, Koch J, Ultsch B, Weidemann F, Wichmann O. Cost-effectiveness of childhood rotavirus vaccination in Germany. Vaccine 2014; 32(17):1964-74; PMID:24561052; http://dx.doi.org/10.1016/j.vaccine.2014.01.061
   PubMed Web of Science ®Google Scholar
• Giammanco MD, Coniglio MA, Pignato S, Giammanco G. An economic analysis of rotavirus vaccination in Italy. Vaccine 2009; 27(29):3904-11; PMID:19446934; http://dx.doi.org/10.1016/j.vaccine.2009.04.002
   PubMed Web of Science ®Google Scholar
• Martin A, Cottrell S, Standaert B. Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK. J Med Econ 2008; 11(3):471-84; PMID:19450099; http://dx.doi.org/10.3111/13696990802321047
   PubMedGoogle Scholar
• Postma MJ, Jit M, Rozenbaum MH, Standaert B, Tu HA, Hutubessy RC. Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world. BMC Med 2011; 9:84; PMID:21740545; http://dx.doi.org/10.1186/1741-7015-9-84
   PubMed Web of Science ®Google Scholar
• Rautenberg TA, Zerwes U, Foerster D, Aultman R. Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD model. Clinicoecon Outcomes Res 2012; 4:109-16; PMID:22570557; http://dx.doi.org/10.2147/CEOR.S31238
   PubMedGoogle Scholar
• Martin A, Batty A, Roberts JA, Standaert B. Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK. Vaccine 2009;27(33):4520-8; PMID:19446594; http://dx.doi.org/10.1016/j.vaccine.2009.05.006
   PubMed Web of Science ®Google Scholar
• Pharmaceuticals and medical devices safety information No. 280. Ministry of Health, Labour and Welfare, Tokyo, June 2011 [access 2016 15 Jun]. Available at: https://www.pmda.go.jp/files/000153635.pdf
   Google Scholar
• Nakagomi O, Nakagomi T. Rotavirus vaccine: Is there a need in Japan. Mordan Media 2008; 54(11):317-30. [Japanese]
   Google Scholar
• Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996; 335(14):1022-8; PMID:8793926; http://dx.doi.org/10.1056/NEJM199610033351404
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354(1):11-22; PMID:16394298; http://dx.doi.org/10.1056/NEJMoa052434
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354(1):23-33; PMID:16394299; http://dx.doi.org/10.1056/NEJMoa052664
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Postmarketing monitoring of intussusception after RotaTeq vaccination–United States, February 1, 2006-February 15, 2007. MMWR 2007; 56(10):218-22; PMID:17363890
   PubMedGoogle Scholar
• Yokoo M, Arisawa K, Nakagomi O. Estimation of annual incidence, age-specific incidence rate, and cumulative risk of rotavirus gastroenteritis among children in Japan. Jpn J Infect Dis 2004; 57(4):166-71; PMID:15329449
   PubMed Web of Science ®Google Scholar
• Kinoshita S, Noguchi A, Miura S, Nakagomi T, Nakagomi O, Takahashi T. A retrospective, hospital-based study to determine the incidence of rotavirus hospitalizations among children less than 5 years of age over a 10-year period (2001-2011) in Akita prefecture, Japan. Jpn J Infect Dis 2014; 67(6):464-8; PMID:25410562; http://dx.doi.org/10.7883/yoken.67.464
   PubMed Web of Science ®Google Scholar
• Lynch M, Lee B, Azimi P, Gentsch J, Glaser C, Gilliam S, Chang HG, Ward R, Glass RI. Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review. Clin Infect Dis 2001; 33(7):932-8; PMID:11528562; http://dx.doi.org/10.1086/322650
   PubMed Web of Science ®Google Scholar
• Bloch KC, Glaser CA. Encephalitis Surveillance through the Emerging Infections Program, 1997-2010. Emerg Infect Dis 2015; 21(9):1562-7; PMID:26295485; http://dx.doi.org/10.3201/eid2109.150295
   PubMed Web of Science ®Google Scholar
• Brisson M, Sénécal M, Drolet M, Mansi JA. Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study. Pediatr Infect Dis J 2010; 29(1):73-5; PMID:19907361; http://dx.doi.org/10.1097/INF.0b013e3181b41506
   PubMed Web of Science ®Google Scholar
• Iwata S, Nakata S, Ukae S, Koizumi Y, Morita Y, Kuroki H, Tanaka Y, Shizuya T, Schödel F, Brown ML, et al. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial. Hum Vaccin Immunother 2013; 9(8):1626-33; PMID:23732903; http://dx.doi.org/10.4161/hv.24846
   PubMed Web of Science ®Google Scholar
• Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, et al. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics 2013; 132(1):e25-33; PMID:23776114; http://dx.doi.org/10.1542/peds.2012-3804
   PubMed Web of Science ®Google Scholar
• Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2012; 11:Cd008521; PMID:23152260
   PubMed Web of Science ®Google Scholar
• Nomoto H, Konishi N, Moriya M, Iwamoto T, Aoki D, Noma Y, Kawamura  . Economic effects of rotavirus gastroenteritis on families of affected infants. J Chugoku Rosai Hospital 2014; 23(1):6-9. [In Japanese]
   Google Scholar
• Iwata S, Ihiwada N, Sakata H, Sakano T, Sato Y, Nakano T, Nishi J, Haruta T, Hoshino N, Kamiya S. Burden of illness of bacterial meningitis and bacteremia caused by Streptococcus pneumonia in children. Jpn J Pediatr 2008; 61:2206-20. [In Japanese]
   Google Scholar
• Ministry of Health, Labour and Welfare. Basic survey on wage structure 2013. Tokyo: Health and Welfare Statistics Association; 2014, [in Japanese]
   Google Scholar
• Nakagomi T, Kato K, Tsutsumi H, Nakagomi O. The burden of rotavirus gastroenteritis among Japanese children during its peak months: an internet survey. Jpn J Infect Dis 2013; 66(4):269-75; PMID:23883835; http://dx.doi.org/10.7883/yoken.66.269
   PubMed Web of Science ®Google Scholar
• Yamanaka N, Hotomi M, Sugita R. Cost-effectiveness of pneumococcal conjugate vaccine in Japan: estimation on acute pneumococcal otitis media in children. Jpn J Pediatr 2008; 61:2221-32. [In Japanese]
   Google Scholar
• Drummond MF, Sculper MJ, Claxton K, Stoddart G, Torrance GW. Methods for the economic evaluation of health care programmes, 4th ed. Oxford, UK: Oxford University Press; 2015
   Google Scholar
• Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford, UK: Oxford University Press; 2006
   Google Scholar